HOME >> MEDICINE >> NEWS
Promising treatments for Huntington's disease identified in UCI study

Irvine, Calif., Feb. 14, 2005 -- UC Irvine researchers have identified several promising drug compounds that when combined show the potential to treat Huntington's disease.

In tests on fruit flies, Larry Marsh and Leslie Thompson found that combinatorial drug therapies developed from these compounds halted the brain-cell damage caused by the fatal, progressive neurodegenerative disorder. Such types of therapies have proven very effective in the treatment of other complex human diseases, like cancers and AIDS. And while any human benefits from this study are years off, the research provides the first evidence that a regimen of complementary drugs can treat Huntington's. Study results appear this week in the early online edition of the Proceedings of the National Academy of Sciences.

"Preclinical testing strategies such as those we used with fruit flies can result in a great savings of cost and time in developing potential disease treatments," Marsh said. "They can serve to rapidly identify treatment regimens that are very likely to provide effective therapeutic benefit to patients."

In developing these drug combinations, Marsh and Thompson chose compounds that individually have been shown in other fruit-fly tests and in mouse models to suppress neurodegeneration, but each targets different cellular processes. Included in these combinations are HDAC inhibitors, which also are showing great promise in cancer-treatment clinical trials. When combined, these compounds showed increased suppression qualities with no toxic side effects.

"That's what's important to note," Marsh said. "Every drug is also a potential poison. Thus, we sought to find several drugs, each of which impacts a different point in the disease process, so that we could use low doses of each single drug, but together their combined effects all converge on a single disease process. This minimizes toxic side effects while maximizing benefit."

Since Huntington's is a
'"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
14-Feb-2005


Page: 1 2 3

Related medicine news :

1. Promising new strategy for Swedish medical research
2. Promising results for malaria vaccine trial
3. Promising diagnostic test for sleeping sickness
4. Promising new treatment options for people with co-existing alcohol-use and psychiatric disorders
5. Promising drug fails to thwart fatal lung disease in large trial
6. Promising drug proves ineffective as treatment for hearing loss
7. Promising West Nile virus vaccine protects monkeys
8. Promising new treatment preserves bone mass in mice; May help women and men with osteoporosis
9. Promising vaccine may provide long-lasting protection against malaria
10. Promising new research on schizophrenia causes
11. UI Study Suggests Promising Treatment For Diabetic Pregnancies

Post Your Comments:
(Date:4/2/2015)... Atlanta-based Kanga, the first SaaS-based platform ... Best Start Up in Atlanta by General Assembly Atlanta. ... Calend.ly, GottaGolf, LOV, Ticket Alternative, and TripTap. T General ... of over 500 at their Atlanta Launch Party at ... and mobile platform for initiating, managing and tracking last ...
(Date:4/1/2015)... April 01, 2015 In April, the ... endeavor to raise autism awareness by illuminating Richmond’s historic ... will be one of thousands of businesses, schools and ... using exterior lighting to brighten up the night sky ... spectrum. This collaborative effort is the 8th annual awareness ...
(Date:4/1/2015)... One year ago today, the USO cut the ribbon on ... States and changed the landscape on Naval Support Activity Bethesda ... more than 100,000 troops and military families in the last ... injured and their families, proving to be a valuable resource ... the country. After opening its doors on the campus that ...
(Date:4/1/2015)... 01, 2015 After a particularly harsh winter, ... potholes can lead to costly damage, so Amica Insurance ... is sharing the following suggestions from AAA: , ... and be inflated to the manufacturer’s recommended levels. , ... excessive vibration and uneven tire wear can be signs of ...
(Date:4/1/2015)... 01, 2015 It all began at home ... Gasbarro, who was on a mission to create a line ... ingredients that parents could trust. Now, Shoosha Truly Organic is ... skincare products, meaning all products contain a minimum 95% certified ... Babies’ skin is considered to be 40% thinner than adults ...
Breaking Medicine News(10 mins):Health News:Kanga Wins Best Start Up in Atlanta 2Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 2Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 3Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 4Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 5Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 3
(Date:4/1/2015)... 2015  The fairness of the proposed acquisition of ... Pharmaceutical Industries ("Teva") is being investigated by WeissLaw LLP, ... investigation focuses on possible breaches of fiduciary duty and ... of ASPX for agreeing to sell the Company to ... definitive agreement for Teva to acquire ASPX in a ...
(Date:4/1/2015)... , April 1, 2015  Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of an offering of $60.0 million aggregate principal ... (the "notes") in a private placement to qualified ... Securities Act of 1933, as amended (the "Act"). ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and Markets ... the "An Introduction to the Medical Device Directives" ... provides a detailed introduction to the European medical device ... are covered, the involvement of Notified Bodies, how to ... It will also cover the documentation necessary to apply ...
Breaking Medicine Technology:WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2
Cached News: